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The primary cause of Duchenne Muscular Dystrophy, a condition that affects 1 in 3500 live male 
births, is a deficiency of the protein dystrophin. This deficiency leads to downregulation of the 
neuronal nitric oxide synthase (nNOS) and lowered production of nitric oxide. This study investigated 
the effects of L-arginine, the substrate of nNOS, on cardiac function and fibrosis in mdx mice, a 
widely used animal model for Duchenne Muscular Dystrophy.  Six month old mice received 5 mg/g 
body weight L-arginine by daily oral gavage for six months.  At the completion of treatment, mice 
were anaesthetised with sodium pentobarbitone (70 mg/kg, ip) prior to euthanasia by excision of the 
heart. Cardiac function was assessed with the Langendorff technique at a perfusion pressure of 80 
mmHg. Mdx mice had an impaired left ventricular developed pressure relative to C57BL10ScSn 
control mice, but this difference was not evident in L-arginine treated mdx mice. The L-arginine 
treated mdx mice also showed an increased coronary flow and reduced diastolic stiffness relative to 
untreated mdx mice (P<0.05).  This reduction in stiffness was associated with a significant reduction 
in cardiac collagen measured as the percent of left ventricular area stained with the collagen specific 
dye picrosirius red (P<0.05). These results indicate that chronic treatment with L-arginine produces 
the beneficial effects of improving function and reducing fibrosis in the dystrophin-deficient heart.    
  
